Table 1. Relationship between expression of ROR2 and Wnt5a tumor tissues and clinicopathological characteristics in NSCLC.

Groups	n	ROR2 expression			Wnt5a expression			ROR2+/Wnt5a+ expression
		High(%)	Pearson χ2	P	High (%)	Pearson χ2	P	ROR2+/Wnt5a+(%)	Pearson χ2	P
Total	219	109(49.77)			78(35.62)			57(26.00)
Age
≤ 60 years	84	37(44.04)	1.786	0.181	30(35.71)	0.001	0.981	21(25.00)	0.075	0.785
> 60 years	135	72(53.33)			48(35.56)			36(26.67)
Gender
Male	167	88(52.69)	2.404	0.121	65(38.92)	3.352	0.067	48(28.74)	2.693	0.101
Female	52	21(40.38)			13(25.00)			9(17.31)
Differentiation
Low grade	48	25(52.08)	0.016	0.898	21(43.75)	0.910	0.340	15(31.25)	0.403	0.526
Middle and high grade	147	75(51.02)			53(36.05)			39(26.53)
Others	24	9			4			3
Histological type
Adenocarcinoma	118	66(55.93)	0.127	0.722	47(39.83)	0.286	0.593	35(29.66)	0.280	0.597
Squamous cell carcinoma	38	20(52.63)			17(44.74)			13(34.21)
Othersa	63				14			9
T
Tis+T1	72	36(50.00)	2.518	0.284	26(36.11)	0.042	0.979	18(25.00)	0.135	0.935
T2	123	59(47.97)			44(35.77)			33(26.83)
T3+T4	21	14(66.67)			8(38.10)			6(28.57)
Unknown	3	0			0
N
N0	120	54(45.00)	2.581	0.275	37(30.83)	2.720	0.257	26(21.67)	2.874	0.238
N1	54	29(53.70)			23(42.59)			18(33.33)
N2	45	26(57.78)			18(40.00)			13(28.89)
TNM stage
0-I	89	35(39.33)	7.627	0.022*	23(25.84)	7.011	0.030*	14(15.73)	9.287	0.010*
II	72	41(56.94)			32(44.44)			26(36.11)
III-IV	55	33(60.00)			23(41.82)			17(30.91)
Unknown	3	0			0

^*P < 0.05

^aothers, Adenosquamous carcinoma and others.